Oncology

  1. Cometriq (cabozantinib)
    Cometriq (cabozantinib)
    by Ipsen Pharma
    for Thyroid Cancer
    €5,844.00
  2. Cotellic (cobimetinib)
    Cotellic (cobimetinib)
    by Roche Registration GmbH
    for Skin Cancer
    €5,970.00
  3. Darzalex (daratumumab)
    Darzalex (daratumumab)
    by Janssen-Cilag International N.V.
    for Multiple Myeloma
    €571.20
  4. Empliciti (elotuzumab)
    Empliciti (elotuzumab)
    by Bristol-Myers Squibb
    for Multiple Myeloma
    €1,299.76
  5. Ibrance (palbociclib)
    Ibrance (palbociclib)
    by Pfizer Limited
    for Breast Cancer
    €2,780.00
  6. Imfinzi (durvalumab)
    Imfinzi (durvalumab)
    by AstraZeneca Pharmaceuticals LP
    for Urothelial Carcinoma, Lung Cancer
    €790.20
  7. Keytruda (pembrolizumab)
    Keytruda (pembrolizumab)
    by Merck Sharp
    for Urothelial Carcinoma, Gastric Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Skin Cancer
    €3,490.00
  8. Kisqali (ribociclib)
    Kisqali (ribociclib)
    by Novartis Europharm Limited
    for Breast Cancer
    €1,936.00
  9. Lonsurf (trifluridine/tipiracil)
    Lonsurf (trifluridine/tipiracil)
    by Les Laboratoires Servier
    for Colorectal Cancer
    €852.00
View as Grid List

Items 19-27 of 39

per page
Set Descending Direction